Michael Kelso

Principal Scientist

Professor Michael Kelso

Professor Michael Kelso is an internationally experienced researcher, with more than 25 years of R&D experience across a wide range of areas in medicinal chemistry, including oncology, antimicrobial drug development and drug formulation.

Prior to joining Race Oncology, he was a Professor of Medicinal Chemistry at the University of Wollongong and earlier in his career a NH&MRC CJ Martin Postdoctoral Research Fellow at the Department of Chemistry, The Scripps Research Institute, CA, USA.

Prof Kelso has published 69 scientific research papers and 7 patents and has attracted 18 grants from the National Health and Medical Research Council (NH&MRC), Australian Research Council (ARC), and the US National Institutes of Health (NIH), as well as industry and charity foundations.

Prof Kelso holds a Bachelor of Medicinal Chemistry (First Class Honours) from the University of Wollongong and a PhD from University of Queensland. He is a member of the Royal Australian Chemical Institute and the American Chemical Society.

To view Professor Michael Kelso’s profile, please click here.